Latest Memorial Sloan–Kettering Cancer Center Stories
Unique Multivalent WT1 Vaccine to be developed across hematological malignancies and solid tumors NEW YORK, Sept.
LMOCF continues to fund research efforts and provides four ways to join the fight during National Ovarian Cancer Awareness Month NEW YORK, Sept.
Contract Results from Recent Merger with MabVax Therapeutics, Inc. SAN DIEGO, Aug. 25, 2014 /PRNewswire/ -- Telik, Inc.
The Mesothelioma Applied Research Foundation (Meso Foundation), in collaboration with Penn’s Abramson Cancer Center, announced that on September 26th it will host a regional conference at the
HERRIMAN, Utah, July 10, 2014 /PRNewswire-USNewswire/ -- The Vascular Access Certification Corporation (VACC) has issued a call to action to hospitals throughout the country to consider encouraging
Leading cancer center selects Allscripts dbMotion(TM) and renews Allscripts Sunrise(TM) relationship to facilitate exceptional community-based patient care CHICAGO, July 9, 2014 /PRNewswire/
A special presentation on mesothelioma, organized by the CancerCare group, will feature two Mesothelioma Applied Research Foundation’s experts. Alexandria,
Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance research NEW YORK and MADISON, N.J., June
BARCELONA, Spain, May 13, 2014 /PRNewswire/ -- With the election of Barcelona as base of Grifols' new fractionation plant, the largest in Europe, the city appears as a
Prize forms part of $25M Pershing Square Sohn Cancer Research Alliance NEW YORK, May 5, 2014 /PRNewswire-USNewswire/ -- The Pershing Square Sohn Cancer Research Alliance today announced the
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.